The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT

International Journal of Colorectal Disease

Volumn 24, Issue 2, 2009, Pages 191-200

  Rosenberg, Robert ^a   Herrmann, Ken ^a   Gertlerr, Ralf ^a   Künzli, Beat ^a   Essler, Markus ^a   Lordick, Florian ^a   Becker, Karen ^a   Schuster, Tibor ^a   Geinitz, Hans ^a   Maak, Matthias ^a   Schwaiger, Markus ^a   Siewert, Jörg Rüdiger ^a   Krause, Bernd ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

PET; Preoperative radiochemotherapy; Rectal cancer; Response

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GLUCOSE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG UPTAKE; FALSE NEGATIVE RESULT; FEMALE; GLUCOSE UTILIZATION; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; LYMPHADENECTOMY; MALE; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECTUM CANCER; RECTUM SURGERY; SENSITIVITY AND SPECIFICITY; TIME; TREATMENT OUTCOME;

ENDOSONOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RECTAL NEOPLASMS; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58549101465     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0616-8     Document Type: Article

References (28)

1. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
2. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740
3. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123
4. Bakx R, Emous M, Legemate DA et al (2006) Harm and benefit of short-term pre-operative radiotherapy in patients with resectable rectal carcinomas. Eur J Surg Oncol 32:520-526
5. Guillem JG, Chessin DB, Cohen AM et al (2005) Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241:829-836
6. Rodel C, Martus P, Papadoupolos T et al (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23:8688-8696
7. Rosenberg R, Nekarda H, Zimmermann F et al (2008) Histopathological response after neoadjuvant radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol 97:8-13
8. Ghadimi BM, Grade M, Difilippantonio MJ et al (2005) Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23:1826-1838
9. Watanabe T, Komuro Y, Kiyomatsu T et al (2006) Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res 66:3370-3374
10. Rimkus C, Friederichs J, Boulesteix AL et al (2008) Microarray-based prediction of tumor response to neoadjuvant chemoradiotherapy of patients with locally advanced rectal cancer. Clin Gastroenterology Hepatology 6:53-61
11. Weber WA, Ott K, Dittler HJ et al (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophaggastric junction by metabolic imaging. J Clin Oncol 19:3058-3065
12. Ott K, Fink U, Becker K et al (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 21:4604-4610
13. Ott K, Weber W, Lordick F et al (2006) Metabolic imaging predicts response, survival, and recurrence in adenocarcinoma of the esophagogastric junction. J Clin Oncol 24:4692-4698
14. Brucher BL, Weber W, Bauer M et al (2001) Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography. Ann Surg 233:300-309
15. Amthauer H, Denecke T, Rau B et al (2004) Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Med Mol Imaging 31:811-819
16. Kalff V, Duong C, Drummond EG et al (2006) Findings on 18 F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 47:14-22
17. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47:1241-1248
18. Becker K, Mueller JD, Schumacher C et al (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98:1521-1530
19. Lordick F, Ott K, Krause BJ et al (2007) Use of PET to assess early metabolic response and guide treatment of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: A prospective feasibility study. Lancet Oncol 8:797-805
20. Capirci C, Rampin L, Erba PA et al. FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging. 2007 May 15; [Epub ahead of print]
21. Capirci C, Rubello D, Chierichetti F et al (2006) Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. Am J Roentgenol 187:202-208
22. Kao PF, Chou YH, Lai CW (2008) Diffuse FDG uptake in acute prostatitis. Clin Nucl Med 33:308-310
23. Oku S, Nakagawa K, Momose T et al (2002) FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer. Ann Nucl Med 16:409-416
24. Saw RP, Morgan M, Koorey D et al (2003) p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy. Dis Colon Rectum 46:192-202
25. Llamas-Elvira JM, Rodrigues-Fenandez AR, Gutierrez-Sainz J et al (2007) Flourine-18 flourodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging 34:859-866
26. Wieder H, Rosenberg R, Lordick F et al (2007) Magnetic resonance imaging in patients with rectal cancer before neoadjuvant radiochemotherapy for prediction of tumor-free circumferential resection margins and long-term survival. Radiology 243:744-751
27. 18F) 3′-deoxy-3′-flourothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer. Eur J Nucl Med Mol Imaging 34:878-883
28. Denecke T, Rau B, Hoffmann KT et al (2005) Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? Eur Radiol 15:1658-1666